Introduction
Prisons are notorious incubators for infectious diseases. Confinement, poor ventilation, and limited access to healthcare create a "perfect storm" for tuberculosis (TB). In Brazil, the incidence of TB among persons deprived of liberty (PPL) is significantly higher than in the general population and has been rising over the last decade. This study investigates the high prevalence of TB within the prison system of Espírito Santo, Brazil, aiming to understand the multi-layered factors—ranging from individual demographics to institutional infrastructure—that influence treatment outcomes.
Methodology
The researchers conducted a retrospective study of TB cases among PPL in Espírito Santo from 2014 to 2016. They employed a hierarchical logistic regression model to analyze data across three distinct tiers:
- Institutional (Distal): Occupancy rates, prison type, and availability of health/education teams.
- Clinical (Intermediate): Comorbidities (HIV/AIDS, diabetes, alcoholism), TB type, and the use of supervised treatment.
- Individual (Proximal): Gender, age, ethnicity, and education level.
Data was integrated from two primary national databases: the SINAN (health notification system) and Infopen (penitentiary information survey), supplemented by state health and justice department reports.
Key Findings
The "Gateway" Risk and Institutional Heterogeneity
TB rates were not uniform across the system, ranging from 0 to 17.3 cases per 1,000 inmates. The Viana Triage Center (CTV), the entry point for the state's prison system, showed the highest rate (17.3 per 1,000) and an occupancy rate exceeding 200%. This identifies the point of entry as a critical zone for both detection and potential transmission.
Treatment Outcomes and the "Transfer Trap"
Of the 300 cases studied, 72.6% achieved a cure. While close to the national average, this remains below the World Health Organization's target of 85%. A significant challenge identified was the "transfer trap": 18.7% of patients were moved between units during treatment, disrupting continuity of care and increasing the risk of loss to follow-up.
The Power of Supervised Treatment
The single most critical factor in ensuring success was supervised treatment (Directly Observed Treatment - DOT). The adjusted analysis showed that supervised treatment significantly prevents treatment failure (CR = 0.29; 95%CI 0.01–0.76). Patients receiving supervised care were roughly 70% less likely to experience a negative treatment outcome, effectively buffering them against the chaotic prison environment.
Vulnerable Sub-populations
Although the prison population is predominantly male, women in the study experienced a higher proportion of treatment failure (71.4% vs. 26.3% in men). This disparity is potentially linked to higher rates of HIV co-infection among female inmates.
Conclusion and Future Directions
The study highlights the urgent need for targeted interventions within the prison system. While supervised treatment is a proven success factor, institutional challenges like overcrowding and frequent inmate transfers must be addressed to reach international cure targets.
Future research should focus on longitudinal tracking of inmates post-release and genetic sequencing of M. tuberculosis strains to better map the transmission dynamics between prisons and the surrounding community. Understanding these factors is essential for implementing measures that reduce treatment failure and protect both the prison population and public health at large.
Summary updated